Currently Investigating
Our firm is once again investigating the cardiovascular dangers of Avandia. One of the most significant side effects observed in clinical trials has been heart attacks. In a study at the Cleveland Clinic, 42 previous studies of Avandia involving over 14,000 patients were analyzed by two researchers. The results of their study showed that Avandia users suffered 43% more heart attacks than those on a placebo medication. This study was published in the New England Journal of Medicine in May of 2007, prompting the FDA to issue a public safety warning and to request a black box warning.
The FDA is presently considering a possible withdrawal of Avandia or significant changes to the "warnings" contained in the product labeling.
If you or a loved one took Avandia and suffered a heart attack, congestive heart failure, liver problems, pulmonary hyptertension, or a stroke, please CONTACT US through this web site or call us TOLL FREE.
Yaz and Yasmin, manufactured by Bayer, are combined oral contraceptives that contain ethinyl estradiol, long used in oral contraceptives, and drospirenone, a new type of progestin that is not used in any other birth control pills approved in the United States.
The warnings for Yaz and Yasmin are simply inadequate; they do not properly indicate that the use of drospirenone increases the risk that women may suffer a variety of side effects, such as:
- Strokes
- Heart attacks
- Pulmonary Embolism (PE)
- Deep Vein Thrombosis (DVT)
- Liver Disease
- Gallbladder Disease
- Kidney Failure
- Sudden Death
Drosprenone can increase blood potassium levels, potentially resulting in a condition known as hyperkalemia, which is known to disrupt heart rhythms and potentially lead to death. Individuals who have pre-existing kidney, liver and adrenal disease could be particularly susceptible.
If you or a loved one took Raptiva and suffered side effects, please CONTACT US through this web site or call us TOLL FREE.
|
